Digital Therapeutics for Sarcopenia Market to Reach $3.21B by 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Digital Therapeutics Sarcopenia Market In 2026, And How Will Its Value Evolve By 2030?
The digital therapeutics sarcopenia market size has seen rapid expansion in recent years. It is anticipated to increase from $1.54 billion in 2025 to $1.78 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 16.1%. The growth observed historically can be ascribed to elements such as the increasing prevalence of an aging population, heightened awareness of health risks linked to sarcopenia, the expansion of telehealth adoption, increasing acceptance of software-based medical therapies, and the early clinical validation of digital interventions.
The digital therapeutics sarcopenia market size is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $3.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 15.9%. This projected growth throughout the forecast period stems from factors such as the heightened demand for home-based care for chronic conditions, the escalating incorporation of AI-powered personalized therapies, broadened reimbursement avenues for digital therapeutics, the expanding uptake of remote patient monitoring, and a reinforced emphasis on solutions for preventive muscle health. Key trends anticipated during this period encompass the wider acceptance of tailored digital therapy programs, the increased utilization of wearable devices for muscle monitoring, the broader implementation of remote physiotherapy platforms, the development of data-informed sarcopenia management strategies, and a stronger commitment to patient involvement and compliance.
Access Your Free Sample Report For In-Depth Market Analysis:
What Major Factors Are Driving The Digital Therapeutics Sarcopenia Market Forward?
The expanding presence of comorbidities is anticipated to fuel the expansion of the digital therapeutics sarcopenia market. Comorbidities are defined as the concurrent existence of multiple health conditions within a single individual. The increase in comorbidities stems from an aging demographic, as older age raises the probability of developing several chronic ailments due to diminishing physiological functions and extended exposure to various health hazards. Digital therapeutics designed for sarcopenia offer advantages in averting comorbidities, particularly obesity, by fostering consistent physical activity and muscle reinforcement, which aids in enhancing metabolism and minimizing fat accumulation. For example, data from March 2024, provided by the World Obesity Federation, a membership body based in the UK, projects that nearly 79% of adults impacted by overweight and obesity will reside in low- and middle-income nations by 2035, with the total count of obese adults forecast to reach 1.53 billion. Consequently, the increasing incidence of comorbidities is propelling the growth of the digital therapeutics sarcopenia market.
How Are Segments Identified Within The Digital Therapeutics Sarcopenia Market Segment Framework?
The digital therapeutics sarcopenia market covered in this report is segmented –
1) By Product: Software, Devices, Services
2) By Distribution Channel: Online Platforms, Direct-To-Consumer Digital Channels, Other Distribution Channels
3) By Application: Muscle Strengthening, Physical Activity Monitoring, Nutrition Management, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Rehabilitation Centers, Other End Users
Subsegments:
1) By Software: Mobile Applications, Web-Based Platforms, AI-Powered Monitoring Tools, Exercise And Rehabilitation Programs, Nutritional Guidance Software
2) By Devices: Wearable Fitness Trackers, Smart Scales, Connected Resistance Bands, Electromyography (EMG) Devices, Muscle Strength Assessment Tools
3) By Services: Remote Patient Monitoring Services, Virtual Physiotherapy Sessions, Teleconsultation Services, Personalized Coaching Services, Data Analytics And Reporting Services
Which Trends Are Impacting The Progress Of The Digital Therapeutics Sarcopenia Market?
Leading companies in the digital therapeutics sarcopenia market are concentrating on developing sophisticated solutions, such as drug discovery platforms. Their objective is to create more targeted therapies, improve treatment effectiveness, and accelerate the provision of personalized care for age-related muscle loss. A drug discovery platform aids in the quicker and more effective identification and creation of new drugs through advanced tools and methods. For example, in April 2025, ProFuse Technology, an Israel-based biotechnology company, unveiled a new drug discovery platform aimed at preventing muscle loss induced by GLP-1 weight-loss drugs, aging (sarcopenia), and cancer cachexia. By employing lab-grown, highly mature muscle tissues that accurately imitate natural muscle, the company can precisely test and screen drug candidates with enhanced speed and efficiency. This advanced platform reduces the dependence on animal testing and decreases research expenses. As the demand for muscle-preserving therapies rises, ProFuse is broadening its scope beyond cultivated meat into the biopharmaceutical industry, offering a pioneering strategy to address increasingly complex muscle health issues.
Who Are The Companies Competing Within The Digital Therapeutics Sarcopenia Market?
Major companies operating in the digital therapeutics sarcopenia market are Sword Health Inc., Biofourmis Inc., Hinge Health Inc., Omada Health Inc., Evolv Rehabilitation Technologies Ltd., Click Therapeutics Inc., DarioHealth Corp., WellDoc Inc., Lark Technologies Inc., Kaia Health Software GmbH, Liva Healthcare A/S, Zibrio Inc., Gait Up SA, Noraxon Inc., Mira Rehab Limited, Cometa Srl., Koneksa Health Inc., Physitrack PLC, Kaia Health Inc., XRHealth USA Inc., MedRhythms Inc.
Get The Full Digital Therapeutics Sarcopenia Market Report:
Which Region Leads The Digital Therapeutics Sarcopenia Market In Overall Market Size?
North America was the largest region in the digital therapeutics sarcopenia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics sarcopenia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Digital Therapeutics Sarcopenia Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Digital Therapeutics Sarcopenia Market 2026, By The Business Research Company
Battery Separators Market Report 2026
https://www.thebusinessresearchcompany.com/report/battery-separators-global-market-report
Cutter Stapler Market Report 2026
https://www.thebusinessresearchcompany.com/report/cutter-stapler-global-market-report
Battery Manufacturing Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
